- Home
- ALUR vs TENX Comparison
ALUR vs TENX Comparison
Compare ALUR & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALUR
- TENX
- Stock Information
- Founded
- ALUR 2009
- TENX 1967
- Country
- ALUR United States
- TENX United States
- Employees
- ALUR N/A
- TENX N/A
- Industry
- ALUR
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- ALUR
- TENX Health Care
- Exchange
- ALUR Nasdaq
- TENX Nasdaq
- Market Cap
- ALUR 24.7M
- TENX 21.7M
- IPO Year
- ALUR N/A
- TENX N/A
- Fundamental
- Price
- ALUR $3.55
- TENX $6.75
- Analyst Decision
- ALUR Strong Buy
- TENX Strong Buy
- Analyst Count
- ALUR 3
- TENX 4
- Target Price
- ALUR $50.00
- TENX $20.67
- AVG Volume (30 Days)
- ALUR 4.1M
- TENX 53.9K
- Earning Date
- ALUR 03-20-2025
- TENX 03-27-2025
- Dividend Yield
- ALUR N/A
- TENX N/A
- EPS Growth
- ALUR N/A
- TENX N/A
- EPS
- ALUR N/A
- TENX N/A
- Revenue
- ALUR $34,754,000.00
- TENX N/A
- Revenue This Year
- ALUR N/A
- TENX N/A
- Revenue Next Year
- ALUR N/A
- TENX N/A
- P/E Ratio
- ALUR N/A
- TENX N/A
- Revenue Growth
- ALUR N/A
- TENX N/A
- 52 Week Low
- ALUR $2.37
- TENX $2.77
- 52 Week High
- ALUR $98.75
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- ALUR 36.72
- TENX 51.52
- Support Level
- ALUR $3.32
- TENX $6.10
- Resistance Level
- ALUR $5.78
- TENX $7.69
- Average True Range (ATR)
- ALUR 0.71
- TENX 0.53
- MACD
- ALUR -0.13
- TENX -0.07
- Stochastic Oscillator
- ALUR 6.05
- TENX 44.12
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.